DELCATH SYSTEMS INC
NASDAQ: DCTH (Delcath Systems, Inc.)
Kemas kini terakhir: 3 jam lalu9.13
-0.07 (-0.76%)
| Penutupan Terdahulu | 9.20 |
| Buka | 9.24 |
| Jumlah Dagangan | 185,083 |
| Purata Dagangan (3B) | 479,874 |
| Modal Pasaran | 322,414,272 |
| Harga / Pendapatan (P/E TTM) | 130.43 |
| Harga / Pendapatan (P/E Ke hadapan) | 25.77 |
| Harga / Jualan (P/S) | 4.39 |
| Harga / Buku (P/B) | 2.93 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| Margin Keuntungan | -26.38% |
| Margin Operasi (TTM) | 3.24% |
| EPS Cair (TTM) | -0.450 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 530.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.27% |
| Nisbah Semasa (MRQ) | 15.95 |
| Aliran Tunai Operasi (OCF TTM) | -6.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.11 M |
| Pulangan Atas Aset (ROA TTM) | -1.51% |
| Pulangan Atas Ekuiti (ROE TTM) | -28.13% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Delcath Systems, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.5 |
| Purata | 1.00 |
|
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.73% |
| % Dimiliki oleh Institusi | 45.84% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Rosalind Advisors, Inc. | 31 Dec 2025 | 3,300,389 |
| Divisadero Street Capital Management, Lp | 31 Dec 2025 | 499,796 |
| Exoduspoint Capital Management, Lp | 31 Dec 2025 | 496,705 |
| Propel Bio Management, Llc | 31 Dec 2025 | 438,509 |
| Ikarian Capital, Llc | 31 Dec 2025 | 431,251 |
| Private Wealth Advisors, Llc | 31 Dec 2025 | 290,481 |
| Palisades Investment Partners, Llc | 31 Dec 2025 | 267,138 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 30.00 (HC Wainwright & Co., 228.59%) | Beli |
| Median | 24.50 (168.35%) | |
| Rendah | 19.00 (BTIG, 108.11%) | Beli |
| Purata | 24.50 (168.35%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 9.67 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 26 Feb 2026 | 19.00 (108.11%) | Beli | 9.00 |
| HC Wainwright & Co. | 09 Jan 2026 | 30.00 (228.59%) | Beli | 10.34 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |